Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies

Harumi Yoshinaga, Shunichi Sakoda, Takashi Shibata, Tomoyuki Akiyama, Makio Oka, Jun Hui Yuan, Hiroshi Takashima, Masanori P. Takahashi, Tetsuro Kitamura, Nagako Murakami, Katsuhiro Kobayashi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background Mutations of the SCN4A gene cause several skeletal muscle channelopathies and overlapping forms of these disorders. However, the variability of the clinical presentation in childhood is confusing and not fully understood among pediatric neurologists. Patients We found three different mutations (p.V445M, p.I693L, and a novel mutation, p.V1149L) in SCN4A but not in the CLCN1 gene. The patient with p.V445M showed the clinical phenotype of sodium channel myotonia, but her clear symptoms did not appear until 11 years of age. Her younger sister and mother, who have the same mutation, displayed marked intrafamilial phenotypic heterogeneity from mild to severe painful myotonia with persistent weakness. The patient with p.I693L exhibited various symptoms that evolved with age, including apneic episodes, tonic muscular contractions during sleep, fluctuating severe episodic myotonia, and finally episodic paralyses. The patient with the novel p.V1149L mutation exhibited episodic paralyses starting at 3 years of age, and myotonic discharges were detected at 11 years of age for the first time. Conclusion The present cohort reveals the complexity, variability, and overlapping nature of the clinical features of skeletal muscle sodium channelopathies. These are basically treatable disorders, so it is essential to consider genetic testing before the full development of a patient's condition.

Original languageEnglish
Pages (from-to)504-508
Number of pages5
JournalPediatric Neurology
Volume52
Issue number5
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Channelopathies
Skeletal Muscle
Sodium
Mutation
Myotonia
Paralysis
Genetic Testing
Muscle Contraction
Genes
Siblings
Sleep
Mothers
Pediatrics
Phenotype

Keywords

  • electromyography
  • genetic testing
  • mutation
  • myotonia
  • periodic paralysis
  • SCN4A
  • sodium channelopathy

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology
  • Medicine(all)

Cite this

Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies. / Yoshinaga, Harumi; Sakoda, Shunichi; Shibata, Takashi; Akiyama, Tomoyuki; Oka, Makio; Yuan, Jun Hui; Takashima, Hiroshi; Takahashi, Masanori P.; Kitamura, Tetsuro; Murakami, Nagako; Kobayashi, Katsuhiro.

In: Pediatric Neurology, Vol. 52, No. 5, 01.05.2015, p. 504-508.

Research output: Contribution to journalArticle

Yoshinaga, H, Sakoda, S, Shibata, T, Akiyama, T, Oka, M, Yuan, JH, Takashima, H, Takahashi, MP, Kitamura, T, Murakami, N & Kobayashi, K 2015, 'Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies', Pediatric Neurology, vol. 52, no. 5, pp. 504-508. https://doi.org/10.1016/j.pediatrneurol.2015.01.014
Yoshinaga, Harumi ; Sakoda, Shunichi ; Shibata, Takashi ; Akiyama, Tomoyuki ; Oka, Makio ; Yuan, Jun Hui ; Takashima, Hiroshi ; Takahashi, Masanori P. ; Kitamura, Tetsuro ; Murakami, Nagako ; Kobayashi, Katsuhiro. / Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies. In: Pediatric Neurology. 2015 ; Vol. 52, No. 5. pp. 504-508.
@article{b94f8060a89a46f28f449cb043f7d9ef,
title = "Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies",
abstract = "Background Mutations of the SCN4A gene cause several skeletal muscle channelopathies and overlapping forms of these disorders. However, the variability of the clinical presentation in childhood is confusing and not fully understood among pediatric neurologists. Patients We found three different mutations (p.V445M, p.I693L, and a novel mutation, p.V1149L) in SCN4A but not in the CLCN1 gene. The patient with p.V445M showed the clinical phenotype of sodium channel myotonia, but her clear symptoms did not appear until 11 years of age. Her younger sister and mother, who have the same mutation, displayed marked intrafamilial phenotypic heterogeneity from mild to severe painful myotonia with persistent weakness. The patient with p.I693L exhibited various symptoms that evolved with age, including apneic episodes, tonic muscular contractions during sleep, fluctuating severe episodic myotonia, and finally episodic paralyses. The patient with the novel p.V1149L mutation exhibited episodic paralyses starting at 3 years of age, and myotonic discharges were detected at 11 years of age for the first time. Conclusion The present cohort reveals the complexity, variability, and overlapping nature of the clinical features of skeletal muscle sodium channelopathies. These are basically treatable disorders, so it is essential to consider genetic testing before the full development of a patient's condition.",
keywords = "electromyography, genetic testing, mutation, myotonia, periodic paralysis, SCN4A, sodium channelopathy",
author = "Harumi Yoshinaga and Shunichi Sakoda and Takashi Shibata and Tomoyuki Akiyama and Makio Oka and Yuan, {Jun Hui} and Hiroshi Takashima and Takahashi, {Masanori P.} and Tetsuro Kitamura and Nagako Murakami and Katsuhiro Kobayashi",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.pediatrneurol.2015.01.014",
language = "English",
volume = "52",
pages = "504--508",
journal = "Pediatric Neurology",
issn = "0887-8994",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies

AU - Yoshinaga, Harumi

AU - Sakoda, Shunichi

AU - Shibata, Takashi

AU - Akiyama, Tomoyuki

AU - Oka, Makio

AU - Yuan, Jun Hui

AU - Takashima, Hiroshi

AU - Takahashi, Masanori P.

AU - Kitamura, Tetsuro

AU - Murakami, Nagako

AU - Kobayashi, Katsuhiro

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Background Mutations of the SCN4A gene cause several skeletal muscle channelopathies and overlapping forms of these disorders. However, the variability of the clinical presentation in childhood is confusing and not fully understood among pediatric neurologists. Patients We found three different mutations (p.V445M, p.I693L, and a novel mutation, p.V1149L) in SCN4A but not in the CLCN1 gene. The patient with p.V445M showed the clinical phenotype of sodium channel myotonia, but her clear symptoms did not appear until 11 years of age. Her younger sister and mother, who have the same mutation, displayed marked intrafamilial phenotypic heterogeneity from mild to severe painful myotonia with persistent weakness. The patient with p.I693L exhibited various symptoms that evolved with age, including apneic episodes, tonic muscular contractions during sleep, fluctuating severe episodic myotonia, and finally episodic paralyses. The patient with the novel p.V1149L mutation exhibited episodic paralyses starting at 3 years of age, and myotonic discharges were detected at 11 years of age for the first time. Conclusion The present cohort reveals the complexity, variability, and overlapping nature of the clinical features of skeletal muscle sodium channelopathies. These are basically treatable disorders, so it is essential to consider genetic testing before the full development of a patient's condition.

AB - Background Mutations of the SCN4A gene cause several skeletal muscle channelopathies and overlapping forms of these disorders. However, the variability of the clinical presentation in childhood is confusing and not fully understood among pediatric neurologists. Patients We found three different mutations (p.V445M, p.I693L, and a novel mutation, p.V1149L) in SCN4A but not in the CLCN1 gene. The patient with p.V445M showed the clinical phenotype of sodium channel myotonia, but her clear symptoms did not appear until 11 years of age. Her younger sister and mother, who have the same mutation, displayed marked intrafamilial phenotypic heterogeneity from mild to severe painful myotonia with persistent weakness. The patient with p.I693L exhibited various symptoms that evolved with age, including apneic episodes, tonic muscular contractions during sleep, fluctuating severe episodic myotonia, and finally episodic paralyses. The patient with the novel p.V1149L mutation exhibited episodic paralyses starting at 3 years of age, and myotonic discharges were detected at 11 years of age for the first time. Conclusion The present cohort reveals the complexity, variability, and overlapping nature of the clinical features of skeletal muscle sodium channelopathies. These are basically treatable disorders, so it is essential to consider genetic testing before the full development of a patient's condition.

KW - electromyography

KW - genetic testing

KW - mutation

KW - myotonia

KW - periodic paralysis

KW - SCN4A

KW - sodium channelopathy

UR - http://www.scopus.com/inward/record.url?scp=84951567391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951567391&partnerID=8YFLogxK

U2 - 10.1016/j.pediatrneurol.2015.01.014

DO - 10.1016/j.pediatrneurol.2015.01.014

M3 - Article

C2 - 25724373

AN - SCOPUS:84951567391

VL - 52

SP - 504

EP - 508

JO - Pediatric Neurology

JF - Pediatric Neurology

SN - 0887-8994

IS - 5

ER -